Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin

NCT00481936 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Corporate reasons unrelated to safety and efficacy

Conditions

Neoplasms, Glandular and Epithelial

Interventions

DRUG: VB6-845

Sponsor

Sesen Bio, Inc.